Summary of Product Characteristics
last updated on the eMC:
15/10/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 15/10/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 10 date of revision of the text
|
|
Updated on 22/01/2009 and displayed until 15/10/2009
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.2 - Posology and method of administration
-
Change to section 4.3 - Contraindications
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.8 - Undesirable Effects
-
Change to section 5.2 - Pharmacokinetic Properties
-
Change to section 5.3 - Preclinical Safety Data
-
Change to section 10 date of revision of the text
|
|
Updated on 20/05/2005 and displayed until 22/01/2009
|
Reasons for adding or updating:
|
-
Change to section 1 - trade name
-
Change to section 2 - qualitative and quantitative composition
-
Change to section 3 - pharmaceutical form
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 6. 4 - Special Precautions for Storage
|
|
Updated on 10/07/2001 and displayed until 20/05/2005
|
Reasons for adding or updating:
|
-
Change from datasheet to SPC
|
|
Updated on 22/06/2001 and displayed until 10/07/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 06/09/1999 and displayed until 22/06/2001
|
Reasons for adding or updating:
|
|
|
|
